DiMarchis quote as follows: Many diseases share the same root causes, which is inhibition of AMPK activity leading to disruption of many metabolic pathways. GLP-1 drugs activate AMPK primarily through reducing calorie intake
Additionally, the company is asking for the associated lawsuits to be dismissed, under a 702 judgment, based on the adequacy of the FDA-approved product labeling and the lack of admissible expert testimony on general causation. This is a common defense tactic in mass litigation, like this MDL for Ozempic and other GLP-1 drugs
A volumizing complex designed to address skin impacted by GLP-1 induced facial volume loss and skin texture decline, featuring ingredients like hyaluronic acid, collagen fragments, bakuchiol, and amino acids
Additionally, higher growth hormone levels help reduce muscle soreness by facilitating the removal of waste products and promoting more efficient nutrient delivery to muscles (4)